Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Planning influenza vaccination programs: a cost benefit model.

Duncan IG, Taitel MS, Zhang J, Kirkham HS.

Cost Eff Resour Alloc. 2012 Jul 26;10(1):10.

PMID:
22835081
[PubMed]
Free PMC Article
2.

Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.

Prosser LA, O'Brien MA, Molinari NA, Hohman KH, Nichol KL, Messonnier ML, Lieu TA.

Pharmacoeconomics. 2008;26(2):163-78.

PMID:
18198935
[PubMed - indexed for MEDLINE]
3.

The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.

Aballéa S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R, Toniolo-Neto J, Drummond M, Weinstein M.

Value Health. 2007 Mar-Apr;10(2):98-116.

PMID:
17391419
[PubMed - indexed for MEDLINE]
4.

Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.

Nichol KL.

Arch Intern Med. 2001 Mar 12;161(5):749-59.

PMID:
11231710
[PubMed - indexed for MEDLINE]
5.

Cost-benefit analysis of in-hospital influenza vaccination of postpartum women.

Ding Y, Zangwill KM, Hay JW, Allred NJ, Yeh SH.

Obstet Gynecol. 2012 Feb;119(2 Pt 1):306-14. doi: 10.1097/AOG.0b013e318242af27.

PMID:
22270282
[PubMed - indexed for MEDLINE]
6.

Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.

Brydak L, Roiz J, Faivre P, Reygrobellet C.

Clin Drug Investig. 2012 Feb 1;32(2):73-85. doi: 10.2165/11594030-000000000-00000.

PMID:
22201294
[PubMed - indexed for MEDLINE]
7.

Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age.

Allsup S, Gosney M, Haycox A, Regan M.

Health Technol Assess. 2003;7(24):iii-x, 1-65.

PMID:
14499051
[PubMed - indexed for MEDLINE]
Free Article
8.

Computer-based multivariate economic analysis of neonatal-intensive-care-unit-based influenza vaccine administration to parents in a low-socio-economic, urban setting.

Shah SI, Caprio M, Sen A, Hendricks-Munoz K.

J Hosp Med. 2007 May;2(3):158-64.

PMID:
17549758
[PubMed - indexed for MEDLINE]
9.

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

Hutton DW, Tan D, So SK, Brandeau ML.

Ann Intern Med. 2007 Oct 2;147(7):460-9.

PMID:
17909207
[PubMed - indexed for MEDLINE]
10.

Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.

Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.

Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44.

PMID:
16330737
[PubMed - indexed for MEDLINE]
11.

Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.

Zhou F, Bisgard KM, Yusuf HR, Deuson RR, Bath SK, Murphy TV.

Pediatrics. 2002 Oct;110(4):653-61.

PMID:
12359777
[PubMed - indexed for MEDLINE]
12.

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization.

Mullooly JP, Bennett MD, Hornbrook MC, Barker WH, Williams WW, Patriarca PA, Rhodes PH.

Ann Intern Med. 1994 Dec 15;121(12):947-52.

PMID:
7978721
[PubMed - indexed for MEDLINE]
13.
14.

Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.

Skowronski DM, Woolcott JC, Tweed SA, Brunham RC, Marra F.

Vaccine. 2006 May 8;24(19):4222-32. Epub 2006 Jan 4.

PMID:
16423432
[PubMed - indexed for MEDLINE]
15.

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

Ryan J, Zoellner Y, Gradl B, Palache B, Medema J.

Vaccine. 2006 Nov 17;24(47-48):6812-22. Epub 2006 Aug 4.

PMID:
17034909
[PubMed - indexed for MEDLINE]
16.

Cost-effectiveness analysis of a rotavirus immunization program for the United States.

Smith JC, Haddix AC, Teutsch SM, Glass RI.

Pediatrics. 1995 Oct;96(4 Pt 1):609-15.

PMID:
7567319
[PubMed - indexed for MEDLINE]
17.

Could a federal program to promote influenza vaccination among elders be cost-effective?

Patel MS, Davis MM.

Prev Med. 2006 Mar;42(3):240-6. Epub 2006 Feb 15.

PMID:
16480761
[PubMed - indexed for MEDLINE]
18.
19.

Cost-effectiveness and potential impact of rotavirus vaccination in the United States.

Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI.

Pediatrics. 2007 Apr;119(4):684-97.

PMID:
17403839
[PubMed - indexed for MEDLINE]
Free Article
20.

Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.

Shepard CW, Ortega-Sanchez IR, Scott RD 2nd, Rosenstein NE; ABCs Team.

Pediatrics. 2005 May;115(5):1220-32.

PMID:
15867028
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk